KIAMED (0747.768.644): annual accounts, directors and company register

KIAMED

Lasne ·KBO/BCE: BE 0747.768.644

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

Company
KIAMED Lasne	€226,294	€442,605	71.6%	-
Dr. Heidi Debels, Plastische Chirurgie Ghent	€198,218	€388,874	36.1%	-
DOKTER TRIFONOV SERGEY Antwerp	€301,859	€403,663	73.3%	-
FERYASU Bertem	€320,778	€419,256	0.0%	-
RADIA Ramillies	€351,305	€365,229	1.4%	-
Maison Médicale Passerelle Santé Louvain La Neuve Ottignies-Louvain-la-Neuve	€158,343	€518,029	71.8%	6.1
Dr. Cedric Depuydt Kortrijk	€269,495	€351,117	96.8%	-

Line	2025	2024	2023	2022	2021	2020
Balance sheet: assets
`20/58`	226,294	342,299	1.0m	851,012	653,494	491,558
`20`	-	-	-	-	-	749
`21/28`	42,460	243,981	232,446	280,013	313,947	332,789
`21`	0	181,410	214,410	247,410	280,410	313,410
`22/27`	42,460	62,571	18,036	32,603	33,537	19,379
`23`	1,117	3,047	4,977	5,604	7,274	-
`24`	41,343	59,524	13,059	26,999	26,262	19,379
`29/58`	183,834	98,318	799,044	570,998	339,547	158,020
`40/41`	21,662	20,000	78,246	10,559	17,815	22,226
`40`	-	-	-	10,559	5,815	3,226
`41`	21,662	20,000	78,246	-	12,000	19,000
`50/53`	-	-	575,000	-	-	-
`54/58`	83,678	39,396	117,939	525,123	315,432	125,147
`490/1`	78,494	38,922	27,858	35,317	6,300	10,647
Balance sheet: equity and liabilities
`10/49`	226,294	342,299	1.0m	851,012	653,494	491,558
`10/15`	161,979	4,977	4,963	669,873	405,466	110,652
`10/11`	4,000	4,000	4,000	4,000	4,000	4,000
`13`	156,000	-	-	-	-	-
`133`	156,000	-	-	-	-	-
`14`	1,979	977	963	665,873	401,466	106,652
`17/49`	64,314	337,322	1.0m	181,139	248,028	380,906
`17`	-	-	39,454	106,497	172,796	238,360
`170/4`	-	-	39,454	106,497	172,796	238,360
`42/48`	64,314	337,322	982,707	74,642	75,232	142,546
`42`	-	39,454	67,042	66,299	65,564	64,838
`44`	1,793	640	1,665	2,139	3,806	968
`440/4`	1,793	640	1,665	2,139	3,806	968
`45`	-	-	-	5,550	5,550	-
`450/3`	-	-	-	5,550	5,550	-
`47/48`	62,521	297,228	914,000	654	312	76,740
`492/3`	-	-	4,365	-	-	-
Income statement
`9900`	442,605	395,044	360,710	396,920	439,434	160,599
`630`	53,112	53,390	40,328	43,115	41,589	19,468
`640/8`	2,020	2,753	474	779	770	1,534
`66A`	148,410	-	-	-	-	-
`9901`	239,063	338,900	319,907	353,027	397,075	139,597
`75/76B`	663	6,317	5,851	5	-	-
`75`	663	6,317	5,851	5	-	-
`65/66B`	1,164	1,757	2,435	3,740	3,764	1,945
`65`	1,164	1,757	2,435	3,740	3,764	1,945
`9903`	238,562	343,460	323,323	349,291	393,311	137,652
`67/77`	81,560	80,446	74,233	84,884	98,498	31,000
`9904`	157,002	263,015	249,090	264,407	294,813	106,652
`9905`	157,002	263,015	249,090	264,407	294,813	106,652
Appropriation of the result
`9906`	157,979	263,977	914,963	665,873	401,466	106,652
`14P`	977	963	665,873	401,466	106,652	-
`691/2`	156,000	-	-	-	-	-
`6921`	156,000	-	-	-	-	-
`694/7`	-	263,000	914,000	-	-	-
`694`	-	263,000	914,000	-	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	30-04-2026	2026-00102900	PDF
31-12-2024	micro format	23-06-2025	2025-00177861	PDF
31-12-2023	micro format	28-03-2024	2024-00058428	PDF
31-12-2022	micro format	26-06-2023	2023-00164754	PDF
31-12-2021	micro format	24-06-2022	2022-20145760	PDF
31-12-2020	micro format	24-06-2021	2021-26000363	PDF

2025	2024	2023	2022	2021	2020
292,174	392,291	360,235	396,141	438,664	159,065
210,114	316,405	289,418	307,522	336,402	126,120
-148,410	64,926	2,750	9,181	21,998	351,500
44,282	-78,543	-407,184	209,692	190,285	-
119,520	-239,004	-183,663	496,357	264,315	15,474
71.6%	1.5%	0.5%	78.7%	62.0%	22.5%
2.86	0.29	0.81	7.65	4.51	1.11
0.40	67.77	-	0.27	0.61	3.44
96.9%	-	-	39.5%	72.7%	96.4%
69.4%	76.8%	24.1%	31.1%	45.1%	21.7%
over 100	over 100	over 100	over 100	over 100	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	€64,926	€2,750	€9,181	€21,998
	€53,112	€53,390	€40,328	€43,115	€41,589

Overview

Lifetime

Key points

Equity

Turnover

Liquidity

Filings

Starting capital

Position in the sector

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Comparable companies

Official details

Annual accounts 2025

Insights on KIAMED

Financials

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency71.6%

Current ratio2.86

Return on assets69.4%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on KIAMED

Board & ownership

Board

Mandates through the years

Control

Capital

Articles of association

Shareholders

Network & group

No group

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Location

Invoicing and payment

in euro

in euro

71.6%

2.86

69.4%